{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T07:41:23Z","timestamp":1715067683809},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,22]]},"DOI":"10.7759\/cureus.27133","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T10:23:30Z","timestamp":1658485410000},"source":"Crossref","is-referenced-by-count":3,"title":["Persistent Relapsing Immune Thrombocytopenia Following COVID-19 Infection"],"prefix":"10.7759","author":[{"given":"Blake A","family":"Boehm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clifford D","family":"Packer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra010501","article-title":"Immune thrombocytopenic purpura","volume":"346","author":"Cines DB","year":"2002","unstructured":"Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med. 2002, 346:995-1008. 10.1056\/NEJMra010501","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.050799","article-title":"Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group","volume":"96","author":"K\u00fchne T","year":"2011","unstructured":"K\u00fchne T, Berchtold W, Michaels LA, et al.. Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group. Haematologica. 2011, 96:1831-7. 10.3324\/haematol.2011.050799","journal-title":"Haematologica"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1810479","article-title":"Immune thrombocytopenia","volume":"381","author":"Cooper N","year":"2019","unstructured":"Cooper N, Ghanima W. Immune thrombocytopenia. N Engl J Med. 2019, 381:945-55. 10.1056\/NEJMcp1810479","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07615.x","article-title":"Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database","volume":"145","author":"Schoonen WM","year":"2009","unstructured":"Schoonen WM, Kucera G, Coalson J, et al.. Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database. Br J Haematol. 2009, 145:235-44. 10.1111\/j.1365-2141.2009.07615.x","journal-title":"Br J Haematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.3.909.415k02_909_913","article-title":"The incidence of idiopathic thrombocytopenic purpura in adults increases with age","volume":"94","author":"Frederiksen H","year":"1999","unstructured":"Frederiksen H, Schmidt K. The incidence of idiopathic thrombocytopenic purpura in adults increases with age. Blood. 1999, 94:909-13. 10.1182\/blood.V94.3.909.415k02_909_913","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert C","year":"2019","unstructured":"Neunert C, Terrell DR, Arnold DM, et al.. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019, 3:3829-66. 10.1182\/bloodadvances.2019000966","journal-title":"Blood Adv"},{"key":"ref7","article-title":"Second-line and subsequent therapies for immune thrombocytopenia (ITP) in adults","author":"Arnold D","year":"2022","unstructured":"Arnold D, Cuker A, Crowther M, Tirnauer J. Second-line and subsequent therapies for immune thrombocytopenia (ITP) in adults. UpToDate. UpToDate, Waltham, MA; 2022."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15090","article-title":"A critical appraisal of the evidence for the role of splenectomy in adults and children with ITP","volume":"181","author":"Rodeghiero F","year":"2018","unstructured":"Rodeghiero F. A critical appraisal of the evidence for the role of splenectomy in adults and children with ITP. Br J Haematol. 2018, 181:183-95. 10.1111\/bjh.15090","journal-title":"Br J Haematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019031039","article-title":"Predictors of relapse and efficacy of rituximab in immune thrombotic thrombocytopenic purpura","volume":"3","author":"Sun L","year":"2019","unstructured":"Sun L, Mack J, Li A, et al.. Predictors of relapse and efficacy of rituximab in immune thrombotic thrombocytopenic purpura. Blood Adv. 2019, 3:1512-8. 10.1182\/bloodadvances.2019031039","journal-title":"Blood Adv"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-020-04019-0","article-title":"Mechanism of thrombocytopenia in COVID-19 patients","volume":"99","author":"Xu P","year":"2020","unstructured":"Xu P, Zhou Q, Xu J. Mechanism of thrombocytopenia in COVID-19 patients. Ann Hematol. 2020, 99:1205-8. 10.1007\/s00277-020-04019-0","journal-title":"Ann Hematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/10408363.2020.1860895","article-title":"COVID-19: from an acute to chronic disease? Potential long-term health consequences","volume":"58","author":"Higgins V","year":"2021","unstructured":"Higgins V, Sohaei D, Diamandis EP, Prassas I. COVID-19: from an acute to chronic disease? Potential long-term health consequences. Crit Rev Clin Lab Sci. 2021, 58:297-310. 10.1080\/10408363.2020.1860895","journal-title":"Crit Rev Clin Lab Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.0c00725","article-title":"Deleterious outcomes in long-hauler COVID-19: the effects of SARS-CoV-2 on the CNS in chronic COVID syndrome","volume":"11","author":"Baig AM","year":"2020","unstructured":"Baig AM. Deleterious outcomes in long-hauler COVID-19: the effects of SARS-CoV-2 on the CNS in chronic COVID syndrome. ACS Chem Neurosci. 2020, 11:4017-20. 10.1021\/acschemneuro.0c00725","journal-title":"ACS Chem Neurosci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-021-01666-x","article-title":"Long COVID, a comprehensive systematic scoping review","volume":"49","author":"Akbarialiabad H","year":"2021","unstructured":"Akbarialiabad H, Taghrir MH, Abdollahi A, et al.. Long COVID, a comprehensive systematic scoping review. Infection. 2021, 49:1163-86. 10.1007\/s15010-021-01666-x","journal-title":"Infection"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/09612033211021161","article-title":"Immune thrombocytopenia and COVID-19: case report and review of literature","volume":"30","author":"Alonso-Beato R","year":"2021","unstructured":"Alonso-Beato R, Morales-Ortega A, Fern\u00e1ndez FJ, Mor\u00f3n AI, R\u00edos-Fern\u00e1ndez R, Rubio JL, Centeno NO. Immune thrombocytopenia and COVID-19: case report and review of literature. Lupus. 2021, 30:1515-21. 10.1177\/09612033211021161","journal-title":"Lupus"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16368","article-title":"Outcomes and management of immune thrombocytopenia secondary to COVID-19: Cleveland clinic experience","volume":"61","author":"Kewan T","year":"2021","unstructured":"Kewan T, Gunaratne TN, Mushtaq K, Alayan D, Daw H, Haddad A. Outcomes and management of immune thrombocytopenia secondary to COVID-19: Cleveland clinic experience. Transfusion. 2021, 61:2014-8. 10.1111\/trf.16368","journal-title":"Transfusion"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s42399-021-01019-7","article-title":"Frequently relapsing post-COVID-19 immune thrombocytopenia","volume":"3","author":"Serrano C","year":"2021","unstructured":"Serrano C, Espa\u00f1ol I, Cascales A, Moraleda JM. Frequently relapsing post-COVID-19 immune thrombocytopenia. SN Compr Clin Med. 2021, 3:2389-92. 10.1007\/s42399-021-01019-7","journal-title":"SN Compr Clin Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17024","article-title":"Clinical characteristics, management and outcome of COVID-19-associated immune thrombocytopenia: a French multicentre series","volume":"190","author":"Mah\u00e9vas M","year":"2020","unstructured":"Mah\u00e9vas M, Moulis G, Andres E, et al.. Clinical characteristics, management and outcome of COVID-19-associated immune thrombocytopenia: a French multicentre series. Br J Haematol. 2020, 190:e224-9. 10.1111\/bjh.17024","journal-title":"Br J Haematol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.9083","article-title":"Immune thrombocytopenia purpura secondary to COVID-19","volume":"12","author":"Bennett J","year":"2020","unstructured":"Bennett J, Brown C, Rouse M, Hoffmann M, Ye Z. Immune thrombocytopenia purpura secondary to COVID-19. Cureus. 2020, 12:e9083. 10.7759\/cureus.9083","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/105878-persistent-relapsing-immune-thrombocytopenia-following-covid-19-infection","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:36:06Z","timestamp":1707507366000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/105878-persistent-relapsing-immune-thrombocytopenia-following-covid-19-infection"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,22]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.27133","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,22]]}}}